Sugammadex in patients with myasthenia gravis: Correspondence

Anaesthesia

Volumn 65, Issue 6, 2010, Pages 653-

  De Boer, H D ^a,b   Van Egmond, J ^a,b   Driessen, J J ^a,b   Booij, L H J D ^a,b  

^a MARTINI HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ROCURONIUM; SUGAMMADEX;

ABSENCE OF SIDE EFFECTS; ANESTHETIC RECOVERY; ARTERIAL PRESSURE; ARTIFICIAL VENTILATION; DEPOLARIZATION; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; HEART RATE; HOMEOSTASIS; HUMAN; LETTER; MUSCLE FUNCTION; MYASTHENIA GRAVIS; NEUROMUSCULAR FUNCTION; SURGICAL TECHNIQUE;

ANDROSTANOLS; GAMMA-CYCLODEXTRINS; HUMANS; MYASTHENIA GRAVIS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; POSTOPERATIVE CARE;

EID: 77952254273     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2010.06360.x     Document Type: Letter

References (4)

1. Unterbuchner C, Fink H, Blobner M. The use of sugammadex in a patient with myasthenia gravis. Anaesthesia 2010 65 : 302 305.
2. Ossenman KE, Jenkens G. Studies on myasthenia gravis. Review of a twenty-year experience in over 1200 patients. The Mount Sinai Journal of Medicine 1971 38 : 497 537.
3. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiologica Scandinavica 2007 51 : 789 808.
4. Tripathi M, Kaushik S, Dubey P. The effect of the use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis. Journal of Postgraduate Medicine 2003 49 : 311 315.